GoodRx Holdings, Inc. Class A GDRX 深 沪
已收盘 03-27 16:00:00 美东时间
1.94
-0.100
-4.90%
华盛通- 最 高2.04
- 今 开2.03
- 成交量 156.68万股
- 最 低 1.94
- 昨 收 2.04
- 总市值 6.65亿
- 52周最高 5.8099
- 市盈率 静 22.74
- 换手率 0.46%
- 52周最低 1.77
- 委 比 36.50%
- 总股本 3.43亿
- 历史最高 64.219
- 量 比 0.75
- 振 幅 4.90%
- 历史最低 1.77
- 每 手 1
- 风险率 0.94%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多GoodRx Chief Accounting Officer Resigns for New Opportunity
The latest announcement is out from GoodRx Holdings ( ($GDRX) ). On March 24, 2...
03-28 05:26
Generic drug suppliers could face pressure from Strait of Hormuz closure
With 90% of prescriptions in the US filled for generic drugs, there is growing concern that supplies of the medications could be in short supply due to the ongoing situation in the Strait of Hormuz, a...
03-17 00:56
BUZZ-Viatris rises as it teams up with GoodRx to offer discounts on brand‑name drugs
BUZZ-Viatris rises as it teams up with GoodRx to offer discounts on brand‑name drugs ** Shares of Viagra and Xanax maker Viatris VTRS.O rise 1.1% to $14.24 ** Co says it partnered with GoodRx GDRX.O to offer discounts of up to 85% on 17 established drugs, including Lipitor, Celebrex, Viagra and Norv
03-11 23:01
GoodRx Awards Performance-Based Bonus to Chief Accounting Officer
GoodRx Holdings ( ($GDRX) ) has shared an announcement. On March 3, 2026, GoodR...
03-07 06:07
Lilly launches program to drive employee access to obesity care
Eli Lilly (LLY) announced on Thursday the launch of the Employer Connect platform, which enables employees to access its obesity therapy Zepbound at a lower cost through a network of pharmacies and a ...
03-05 20:38
Eli Lilly Targets Employer Coverage Gap With New Obesity Drug Access Platform
Eli Lilly (NYSE: LLY) launches Employer Connect platform on March 5, 2026, offering Zepbound tirzepatide KwikPen at $449 across all doses to expand employer-sponsored obesity coverage.
03-05 20:16
Lilly launches employer-connect platform to broaden weight-loss drug access
Lilly launches employer-connect platform to broaden weight-loss drug access March 5 (Reuters) - Eli Lilly LLY.N said on Thursday it had rolled out a platform to help employers connect with organizations offering low-cost benefits and comprehensive obesity-care programs, aiming to widen access to its
03-05 19:01
美股大行评级 | 7家上调，3家下调！CrowdStrike绩后大行评级现分歧；罗斯百货、塔吉特、Viking获多家大行上调目标价
今日重点评级关注：古根海姆：维持Dianthus Therapeutics"买入"评级，目标价从100美元升至200美元；HC Wainwright & Co.：维持Amylyx Pharmaceuticals"买入"评级，目标价从28美元升至34美元
03-05 13:56
美股大行评级 | 绩后暴跌超22%，MongoDB遭14家大行集团下调目标价；挪威邮轮、阿莎娜、Quantum Computing等也遭大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NRX Pharmaceuticals"买入"评级，目标价从40美元升至45美元；RBC Capital：维持NUVATION BIO"跑赢大市"评级，目标价从12美元升至13美元
03-04 10:22
美股大行评级 | 花旗：维持康菲石油"买入"评级！目标价从125美元升至135美元
今日重点评级关注：HC Wainwright & Co.：维持Helus Pharma"买入"评级，目标价从55美元升至95美元；HC Wainwright & Co.：维持Compass Pathways"买入"评级，目标价从40美元升至70美元
03-03 20:22
